These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25146708)

  • 1. Impact of revascularization for patients who survive life-threatening ventricular arrhythmias.
    Lindsay BD
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25146708
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the arrhythmic risk of patients with ischaemic cardiomyopathy really benefit from revascularisation therapy?
    Kallergis EM; Mavrakis HE; Vardas PE
    Hellenic J Cardiol; 2008; 49(4):203-6. PubMed ID: 18935706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of coronary artery revascularization and aneurysmectomy in ventricular arrhythmias in the chronic phase of myocardial infarction].
    Felices Nieto A; Pavón García M; Barquero Aroca JM; Infantes Alcón C; Nieto Gutiérrez P; Ruiz Navas F; Cruz Fernández JM
    Rev Esp Cardiol; 2002 Oct; 55(10):1052-6. PubMed ID: 12383390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable defibrillators for secondary prevention of sudden cardiac death in cardiac surgery patients with perioperative ventricular arrhythmias.
    Nageh MF; Kim JJ; Chen LH; Yao JF
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25146702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Updated ESC guideline: innovations for the treatment of ventricular arrhythmias and recommendations for prevention of sudden cardiac death].
    Eckardt L; Deneke T
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):288-94. PubMed ID: 27581243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitachyarrhythmic interventions of implantable cardioverter-defibrillator in primary and secondary sudden cardiac death prevention patients].
    Piekarz J; Rydlewska A; Majewski J; Lelakowski J
    Pol Merkur Lekarski; 2012 Jun; 32(192):368-73. PubMed ID: 22891561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Have increasing rates of defibrillator implantation reduced the incidence of out-of-hospital cardiac arrest?
    Raitt MH
    Heart Rhythm; 2004 Sep; 1(3):260-1. PubMed ID: 15851166
    [No Abstract]   [Full Text] [Related]  

  • 9. The nature of the game.
    Sweeney MO
    J Cardiovasc Electrophysiol; 2005 May; 16(5):483-5. PubMed ID: 15877618
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction in ventricular arrhythmias and mortality in the primaries: a real-life win-win for CRT-Ds?
    Mehta NK; Abraham WT
    Europace; 2015 Jul; 17(7):1001-2. PubMed ID: 26071231
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    McComb JM; Camm AJ
    BMJ; 2002 Nov; 325(7372):1050-1. PubMed ID: 12424150
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular arrhythmias in patients with implanted cardioverter defibrillators.
    John RM; Stevenson WG
    Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pacing for prevention of ventricular arrhythmias: time for a pause.
    Wilber DJ
    Heart Rhythm; 2006 May; 3(5):581-2. PubMed ID: 16648065
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.
    Cook JR; Rizo-Patron C; Curtis AB; Gillis AM; Bigger JT; Kutalek SP; Coromilas J; Hofer BI; Powell J; Hallstrom AP;
    Am Heart J; 2002 May; 143(5):821-6. PubMed ID: 12040343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients.
    De Sutter J; Tavernier R; De Buyzere M; Jordaens L; De Backer G
    J Am Coll Cardiol; 2000 Sep; 36(3):766-72. PubMed ID: 10987597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
    Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.